These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36208009)

  • 1. Pentoxifylline in dermatology.
    Balazic E; Axler E; Konisky H; Khanna U; Kobets K
    J Cosmet Dermatol; 2023 Feb; 22(2):410-417. PubMed ID: 36208009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generalised granuloma annulare successfully treated with pentoxifylline.
    Rubel DM; Wood G; Rosen R; Jopp-McKay A
    Australas J Dermatol; 1993; 34(3):103-8. PubMed ID: 8080410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granuloma annulare: strengthening potential associations and pentoxifylline as a therapeutic option.
    Visconti MJ; Ashack KA; Ashack RJ
    J Dermatolog Treat; 2021 Jun; 32(4):381-382. PubMed ID: 31464543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentoxifylline: a new drug for the treatment of intermittent claudication. Mechanism of action, pharmacokinetics, clinical efficacy and adverse effects.
    Aviado DM; Porter JM
    Pharmacotherapy; 1984; 4(6):297-307. PubMed ID: 6393073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cilostazol for intermittent claudication.
    Brown T; Forster RB; Cleanthis M; Mikhailidis DP; Stansby G; Stewart M
    Cochrane Database Syst Rev; 2021 Jun; 6(6):CD003748. PubMed ID: 34192807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conservative management of intermittent claudication.
    Radack K; Wyderski RJ
    Ann Intern Med; 1990 Jul; 113(2):135-46. PubMed ID: 2141775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentoxifylline for intermittent claudication.
    Broderick C; Forster R; Abdel-Hadi M; Salhiyyah K
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD005262. PubMed ID: 33063850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pentoxifylline for intermittent claudication.
    Salhiyyah K; Forster R; Senanayake E; Abdel-Hadi M; Booth A; Michaels JA
    Cochrane Database Syst Rev; 2015 Sep; 9(9):CD005262. PubMed ID: 26417854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentoxifylline for intermittent claudication.
    Salhiyyah K; Senanayake E; Abdel-Hadi M; Booth A; Michaels JA
    Cochrane Database Syst Rev; 2012 Jan; 1():CD005262. PubMed ID: 22258961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentoxifylline: a new agent for intermittent claudication.
    Baker DE; Campbell RK
    Drug Intell Clin Pharm; 1985 May; 19(5):345-8. PubMed ID: 3891279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cilostazol for intermittent claudication.
    Bedenis R; Stewart M; Cleanthis M; Robless P; Mikhailidis DP; Stansby G
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD003748. PubMed ID: 25358850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease.
    Chopra HK; Chopra KL; Aggarwal KK; Parashar SK
    J Med; 1988; 19(2):89-107. PubMed ID: 3049876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pentoxifylline in the nonoperative management of intermittent claudication.
    Kokesh J; Kazmers A; Zierler RE
    Ann Vasc Surg; 1991 Jan; 5(1):66-70. PubMed ID: 1997079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost effectiveness of cilostazol compared with naftidrofuryl and pentoxifylline in the treatment of intermittent claudication in the UK.
    Guest JF; Davie AM; Clegg JP
    Curr Med Res Opin; 2005 Jun; 21(6):817-26. PubMed ID: 15969881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acenocoumarol and pentoxifylline in intermittent claudication. A controlled clinical study. The APIC Study Group.
    Dettori AG; Pini M; Moratti A; Paolicelli M; Basevi P; Quintavalla R; Manotti C; Di Lecce C
    Angiology; 1989 Apr; 40(4 Pt 1):237-48. PubMed ID: 2650578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review the efficacy and safety of cilostazol, pentoxifylline, beraprost in the treatment of intermittent claudication: A network meta-analysis.
    Liang X; Wang Y; Zhao C; Cao Y
    PLoS One; 2022; 17(11):e0275392. PubMed ID: 36318524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug treatment of intermittent claudication.
    Jacoby D; Mohler ER
    Drugs; 2004; 64(15):1657-70. PubMed ID: 15257627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of pentoxifylline in geriatric patients with intermittent claudication.
    Crowder JE; Cohn JB; Savitsky JP; Morgan DL; Slywka J; Cobert BL; Hryniewicki SW; Piccirillo RT; Wilcox CS
    Angiology; 1989 Sep; 40(9):795-802. PubMed ID: 2669564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pentoxifylline--a new drug for the treatment of intermittent claudication.
    Chopra HK; Chopra KL; Aggarwal KK; Parashar SK
    Indian Heart J; 1989; 41(2):127-33. PubMed ID: 2744799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of intermittent claudication with pentoxifylline: meta-analysis of randomized controlled trials.
    Hood SC; Moher D; Barber GG
    CMAJ; 1996 Oct; 155(8):1053-9. PubMed ID: 8873633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.